Recruiting Leukemia Studies in Marseille
A Study to Evaluate S227928 as a Single Agent and in Combination With Venetoclax in Patients With R/R AML, MDS/AML, or CMML
The objective of this study is to determine the safety, tolerability, and anti-leukemic activity of S227928 as single agent and in combination with venetoclax, and to determine the recommended Phase 2...
KRT-232 and TKI Study in Chronic Myeloid Leukemia
This study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2, for the treatment of patients with Ph+ Chronic Myeloid Leukemia (CML) who have relapsed or are refractory or intolerant to ...
About Leukemia Clinical Trials in Marseille
Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.
There are currently 2 leukemia clinical trials recruiting participants in Marseille, . These studies are seeking a combined 241 participants. Research is being sponsored by Servier Bio-Innovation LLC, Kartos Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Leukemia Clinical Trials in Marseille — FAQ
Are there leukemia clinical trials in Marseille?
Yes, there are 2 leukemia clinical trials currently recruiting in Marseille, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Marseille?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Marseille research site will contact you about next steps.
Are clinical trials in Marseille free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Marseille studies also compensate for your time and travel.
What leukemia treatments are being tested?
The 2 active trials in Marseille are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.
Data updated March 2, 2026 from ClinicalTrials.gov